308
Views
39
CrossRef citations to date
0
Altmetric
Review

Apoptosis and tumor resistance conferred by Par-4

Pages 1867-1874 | Published online: 01 Dec 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rosana A. Silveira, Angela A. Fachel, Yuri B. Moreira, Carmino A. De Souza, Fernando F. Costa, Sergio Verjovski-Almeida & Katia B. B. Pagnano. (2014) Protein-coding genes and long noncoding RNAs are differentially expressed in dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib. Hematology 19:1, pages 31-41.
Read now

Articles from other publishers (38)

J. Labahn & U. K. Tiruttani Subhramanyam. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4 127 150 .
Sehamuddin Galadari, Anees Rahman Cheratta & Faisal Thayyullathil. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4 263 291 .
Saptadwipa Ganguly, Ravshan Burikhanov, Shirley Qiu & Vivek M. Rangnekar. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4 1 59 .
Anees Rahman Cheratta, Faisal Thayyullathil, Siraj Pallichankandy, Karthikeyan Subburayan, Ameer Alakkal & Sehamuddin Galadari. (2021) Prostate apoptosis response-4 and tumor suppression: it’s not just about apoptosis anymore. Cell Death & Disease 12:1.
Crossref
Jeevan Ghosalkar, Vinay Sonawane, Mohsina Khan, Kalpana Joshi & Padma Shastry. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4 77 111 .
Seema Gupta, Amogh Narendra, Satvik Lolla, Muskan Qureshi, Muhammad Hamza Qureshi & Mansoor M. Ahmed. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4 69 76 .
François Fabi, Pascal Adam & Eric Asselin. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4 41 58 .
Ravshan Burikhanov & Vivek M. Rangnekar. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4 313 320 .
Cláudia Malheiros Coutinho-Camillo, Ágatha Nagli de Mello Gomes, Fernanda de Paula, Maria Aparecida Nagai & Silvia Vanessa Lourenço. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4 269 279 .
Mir Mohd Faheem, Archana Katoch & Anindya Goswami. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4 1 23 .
Gabriela M. da Silva, Victoria Saavedra, Renata C. F. Ianez, Elen A. de Sousa, Ágatha N. Gomes, Natalie Kelner, Maria A. Nagai, Luiz P. Kowalski, Fernando A. Soares, Silvia V. Lourenço & Cláudia M. Coutinho‐Camillo. (2019) Apoptotic signaling in salivary mucoepidermoid carcinoma. Head & Neck 41:9, pages 2904-2913.
Crossref
Ágatha Nagli Gomes, Maria Aparecida Nagai, Silvia Vanessa Lourenço & Cláudia Malheiros Coutinho‐Camillo. (2019) Apoptosis and proliferation during human salivary gland development. Journal of Anatomy 234:6, pages 830-838.
Crossref
Renata Virgínia Cavalcanti Santos, Wanessa Layssa Batista de Sena, Flaviana Alves dos Santos, Antônio Felix da Silva Filho, Marina Galdino da Rocha Pitta, Maira Galdino da Rocha Pitta, Moacyr Barreto de Melo Rego & Michelly Cristiny Pereira. (2019) Potential Therapeutic Agents Against Par-4 Target for Cancer Treatment: Where Are We Going?. Current Drug Targets 20:6, pages 635-654.
Crossref
François Fabi, Pascal Adam, Keven Vincent, Françis Demontigny, Sophie Parent, France-Hélène Joncas & Eric Asselin. (2018) Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death. Cell Communication and Signaling 16:1.
Crossref
Jian Zhang, Aiyou Sun, Yuguo Dong & Dongzhi Wei. (2017) Recombinant Production and Characterization of SAC, the Core Domain of Par-4, by SUMO Fusion System. Applied Biochemistry and Biotechnology 184:4, pages 1155-1167.
Crossref
Zenghuang Ma & Xiaojie Xue. (2017) Differentially expressed proteins in the human esophageal cancer cell line Eca‑109, in the presence and absence of gemcitabine. Molecular Medicine Reports.
Crossref
Udaya K Tiruttani Subhramanyam, Jan Kubicek, Ulf B Eidhoff & Joerg Labahn. (2017) Structural basis for the regulatory interactions of proapoptotic Par-4. Cell Death & Differentiation 24:9, pages 1540-1547.
Crossref
Simone Aparecida De Bessa Garcia, Ana Carolina Pavanelli, Natália Cruz E Melo & Maria Aparecida Nagai. (2017) Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity. International Journal of Molecular Medicine 39:4, pages 809-818.
Crossref
James Sledziona & Vivek M. Rangnekar. 2017. TRAIL, Fas Ligand, TNF and TLR3 in Cancer. TRAIL, Fas Ligand, TNF and TLR3 in Cancer 91 106 .
Shayan Sarkar, Sumeet Jain, Vineeta Rai, Dipak K. Sahoo, Sumita Raha, Sujit Suklabaidya, Shantibhusan Senapati, Vivek M. Rangnekar, Indu B. Maiti & Nrisingha Dey. (2015) Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells. Frontiers in Plant Science 6.
Crossref
Seon Min Woo & Taeg Kyu Kwon. (2015) Prostate Apoptosis Response-4 (Par-4) as a Cancer Therapeutic Target. Journal of Life Science 25:8, pages 947-952.
Crossref
Nicholas C Wong, Vivek A Bhadri, Jovana Maksimovic, Mandy Parkinson-Bates, Jane Ng, Jeff M Craig, Richard Saffery & Richard B Lock. (2014) Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance. BMC Genomics 15:1.
Crossref
Udaya Kumar Tiruttani Subhramanyam, Jan Kubicek, Ulf B. Eidhoff & Joerg Labahn. (2014) Cloning, expression, purification, crystallization and preliminary crystallographic analysis of the C-terminal domain of Par-4 (PAWR). Acta Crystallographica Section F Structural Biology Communications 70:9, pages 1224-1227.
Crossref
P Chaudhry, F Fabi, M Singh, S Parent, V Leblanc & E Asselin. (2014) Prostate apoptosis response-4 mediates TGF-β-induced epithelial-to-mesenchymal transition. Cell Death & Disease 5:2, pages e1044-e1044.
Crossref
William W. Du, Xianmin Li, Tianbi Li, Haoran Li, Anna Khorshidi & Burton B Yang. (2014) Expression of microRNA miR-17-3p inhibits mouse cardiac fibroblast senescence by targeting Par4. Journal of Cell Science.
Crossref
Cláudia Malheiros Coutinho-Camillo, Silvia Vanessa Lourenço, Suely Nonogaki, José Guilherme Vartanian, Maria Aparecida Nagai, Luiz Paulo Kowalski & Fernando Augusto Soares. (2013) Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas. Virchows Archiv 463:1, pages 31-39.
Crossref
Nidhi Shukla, Nikhil K. Hebbar & Vivek M. Rangnekar. 2013. Prostate Cancer. Prostate Cancer 481 495 .
Nikhil Hebbar, Chi Wang & Vivek M. Rangnekar. (2012) Mechanisms of apoptosis by the tumor suppressor Par‐4. Journal of Cellular Physiology 227:12, pages 3715-3721.
Crossref
Mario Gonzalez-Gronow, Salvatore V. Pizzo & Uma K. Misra. 2012. Cellular Trafficking of Cell Stress Proteins in Health and Disease. Cellular Trafficking of Cell Stress Proteins in Health and Disease 229 242 .
Petrus Jansen van Vuren, Caroline T. Tiemessen & Janusz T. Paweska. (2011) Anti-Nucleocapsid Protein Immune Responses Counteract Pathogenic Effects of Rift Valley Fever Virus Infection in Mice. PLoS ONE 6:9, pages e25027.
Crossref
Erhard Bieberich. (2010) There is More to a Lipid than just Being a Fat: Sphingolipid-Guided Differentiation of Oligodendroglial Lineage from Embryonic Stem Cells. Neurochemical Research 36:9, pages 1601-1611.
Crossref
V. Rossi, G. Bellastella, C. De Rosa, C. Abbondanza, D. Visconti, L. Maione, P. Chieffi, F. Della Ragione, D. Prezioso, A. De Bellis, A. Bellastella & A.A. Sinisi. (2011) Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptorα and β. Journal of Cellular Physiology 226:5, pages 1334-1339.
Crossref
Simone A. de Bessa Garcia, Michelly C. Pereira & Maria A. Nagai. (2010) Expression Pattern of the Pro-apoptotic Gene PAR-4 During the Morphogenesis of MCF-10A Human Mammary Epithelial Cells. Cancer Microenvironment 4:1, pages 33-38.
Crossref
Antonio Franchitto, Alessia Torrice, Rossella Semeraro, Cristina Napoli, Gennaro Nuzzo, Felice Giuliante, Gianfranco Alpini, Guido Carpino, Pasquale Bartolomeo Berloco, Luciano Izzo, Antonio Bolognese, Paolo Onori, Anastasia Renzi, Alfredo Cantafora, Eugenio Gaudio & Domenico Alvaro. (2010) Prostate Apoptosis Response-4 Is Expressed in Normal Cholangiocytes, Is Down-Regulated in Human Cholangiocarcinoma, and Promotes Apoptosis of Neoplastic Cholangiocytes When Induced Pharmacologically. The American Journal of Pathology 177:4, pages 1779-1790.
Crossref
T Shrestha-Bhattarai & V M Rangnekar. (2010) Cancer-selective apoptotic effects of extracellular and intracellular Par-4. Oncogene 29:27, pages 3873-3880.
Crossref
Masanori Sato, Virginia J. Yao, Wadih Arap & Renata Pasqualini. 2010. Tissue-Specific Vascular Endothelial Signals and Vector Targeting, Part B. Tissue-Specific Vascular Endothelial Signals and Vector Targeting, Part B 97 114 .
Martin Schwalbe, Kaushik Dutta, David S. Libich, Hariprasad Venugopal, Jolyon K. Claridge, David A. Gell, Joel P. Mackay, Patrick J. B. Edwards & Steven M. Pascal. (2010) Two-state conformational equilibrium in the Par-4 leucine zipper domain. Proteins: Structure, Function, and Bioinformatics, pages n/a-n/a.
Crossref
David S. Libich, Martin Schwalbe, Sachin Kate, Hariprasad Venugopal, Jolyon K. Claridge, Patrick J. B. Edwards, Kaushik Dutta & Steven M. Pascal. (2009) Intrinsic disorder and coiled-coil formation in prostate apoptosis response factor 4. FEBS Journal 276:14, pages 3710-3728.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.